Ashraf Aboelela
Asyut, AST, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Synthesis and characterization of magnetic Ag-Fe3O4@polymer hybrid nanocomposite systems with promising antibacterial application.
Journal: Drug development and industrial pharmacy
Published: October 31, 2023
Automated Patch Clamp Screening of Amiloride and 5-N,N-Hexamethyleneamiloride Analogs Identifies 6-Iodoamiloride as a Potent Acid-Sensing Ion Channel Inhibitor.
Journal: Molecular pharmaceutics
Published: June 01, 2023
A dual-targeting succinate dehydrogenase and F1Fo-ATP synthase inhibitor rapidly sterilizes replicating and non-replicating Mycobacterium tuberculosis.
Journal: Cell chemical biology
Published: May 08, 2023
Morphologic design of nanogold carriers for a carbonic anhydrase inhibitor: Effect on ocular retention and intraocular pressure.
Journal: International journal of pharmaceutics
Published: March 12, 2023
6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist.
Journal: Biomolecules
Published: August 09, 2022
Insight into the Inclusion Complexation of Fluconazole with Sulfonatocalix[4]naphthalene in Aqueous Solution, Solid-State, and Its Antimycotic Activity.
Journal: Molecules (Basel, Switzerland)
Published: June 19, 2022
Silver Nanoparticles Stabilized by Poly (Vinyl Pyrrolidone) with Potential Anticancer Activity towards Prostate Cancer.
Journal: Bioinorganic chemistry and applications
Published: March 21, 2022
Screening of 5- and 6-Substituted Amiloride Libraries Identifies Dual-uPA/NHE1 Active and Single Target-Selective Inhibitors.
Journal: International journal of molecular sciences
Published: February 22, 2021
Systematic evaluation of structure-property relationships and pharmacokinetics in 6-(hetero)aryl-substituted matched pair analogs of amiloride and 5-(N,N-hexamethylene)amiloride.
Journal: Bioorganic & medicinal chemistry
Published: November 26, 2020
6-Substituted amiloride derivatives as inhibitors of the urokinase-type plasminogen activator for use in metastatic disease.
Journal: Bioorganic & medicinal chemistry letters
Published: August 30, 2019
6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer.
Journal: Journal of medicinal chemistry
Published: August 22, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026